Combined advanced prostate cancer treatments: are they additive?

被引：0
|
作者：
Srivastava, Abhishek [1 ]
Shore, Neal D.
机构：
[1] Atlantic Urol Clin, Myrtle Beach, SC 29572 USA
来源：
NATURE REVIEWS UROLOGY | 2021年 / 18卷 / 06期
关键词：
SIPULEUCEL-T; RADIOTHERAPY; IMMUNOTHERAPY; RADIUM-223; IPILIMUMAB; PLACEBO; TRIAL;
D O I：
10.1038/s41585-021-00459-z
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
More than 50 clinical trials are currently exploring the combination of immunotherapy and other approved treatments for advanced prostate cancer. The results from a phase II trial of sipuleucel-T with or without radium-223 in patients with metastatic castration-resistant prostate cancer were recently published with intriguing findings.
引用
收藏
页码：325 / 326
页数：2
相关论文
共 50 条
  • [21] Integration of immunotherapy into the management of advanced prostate cancer
    Kantoff, Philip
    Higano, Celestia S.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2012, 30 (05) : S41 - S47
  • [22] Combined External Radiotherapy and Hormone Therapy in Patients with Locally Advanced Prostate Cancer: Predictive Factors of Genitourinary Toxicity
    Ferrandis, C.
    March, J. A.
    Martinez, J. M.
    Hernandez, J.
    Diez, N.
    Morillo, V.
    Garcia, F.
    Chuan, P.
    ACTAS UROLOGICAS ESPANOLAS, 2011, 35 (03): : 146 - 151
  • [23] Immune Therapy for Prostate Cancer
    Yeku, Oladapo
    Slovin, Susan F.
    CANCER JOURNAL, 2016, 22 (05) : 334 - 341
  • [24] Immune Checkpoint Inhibitors in Advanced Prostate Cancer: Current Data and Future Perspectives
    Rebuzzi, Sara Elena
    Rescigno, Pasquale
    Catalano, Fabio
    Mollica, Veronica
    Vogl, Ursula Maria
    Marandino, Laura
    Massari, Francesco
    Mestre, Ricardo Pereira
    Zanardi, Elisa
    Signori, Alessio
    Buti, Sebastiano
    Bauckneht, Matteo
    Gillessen, Silke
    Banna, Giuseppe Luigi
    Fornarini, Giuseppe
    CANCERS, 2022, 14 (05)
  • [25] Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study)
    Lane, Janet Athene
    Donovan, Jenny L.
    Young, Grace J.
    Davis, Michael
    Walsh, Eleanor, I
    Avery, Kerry N. L.
    Blazeby, Jane M.
    Mason, Malcolm D.
    Martin, Richard M.
    Peters, Tim J.
    Turner, Emma L.
    Wade, Julia
    Bollina, Prasad
    Catto, James W. F.
    Doherty, Alan
    Gillatt, David
    Gnanapragasam, Vincent
    Hughes, Owen
    Kockelbergh, Roger
    Kynaston, Howard
    Oxley, Jon
    Paul, Alan
    Paez, Edgar
    Rosario, Derek J.
    Rowe, Edward
    Staffurth, John
    Neal, David E.
    Hamdy, Freddie C.
    Metcalfe, Chris
    BJU INTERNATIONAL, 2022, 130 (03) : 370 - 380
  • [26] The new era of prostate-specific membrane antigen-directed immunotherapies and beyond in advanced prostate cancer: a review
    Martin, Felicity C.
    Dorff, Tanya B.
    Tran, Ben
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [27] Emerging treatments in advanced urothelial cancer
    Alhalabi, Omar
    Campbell, Matthew
    Shah, Amishi
    Siefker-Radtke, Arlene
    Gao, Jianjun
    CURRENT OPINION IN ONCOLOGY, 2020, 32 (03) : 232 - 239
  • [28] Treatment of Advanced Prostate Cancer
    Teo, Min Yuen
    Rathkopf, Dana E.
    Kantoff, Philip
    ANNUAL REVIEW OF MEDICINE, VOL 70, 2019, 70 : 479 - 499
  • [29] Management of advanced prostate cancer
    von Eyben, F.
    Kiljunen, T.
    Kangasmaki, A.
    Kairemo, K.
    von Eyben, R.
    Joensuu, T.
    ANNALS OF ONCOLOGY, 2015, 26 (11) : 2354 - 2354
  • [30] Management of Advanced Prostate Cancer in the Precision Oncology Era
    Gillette, Claire M. M.
    Yette, Gabriel A. A.
    Cramer, Scott D. D.
    Graham, Laura S. S.
    CANCERS, 2023, 15 (09)
12345